ASSESSING TUMOR RESPONSE TO CHEMOTHERAPY IN PEDIATRIC METASTATIC COLORECTAL CANCER: THE USE OF CEA AND FDG-PET/CT

被引：0
|
作者：
Drezner, Nicole [1 ]
Doros, Leslie [1 ]
Rossi, Chris [1 ]
机构：
[1] Childrens Natl Med Ctr, Washington, DC 20010 USA
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [41] Performance of FDG-PET/CT in postoperative colorectal cancer patients with a suspected recurrent finding and a normal CEA level
    Lee, Jai Hyuen
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [42] The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels
    Yasemin Sanli
    Serkan Kuyumcu
    Zeynep Gozde Ozkan
    Leyla Kilic
    Emre Balik
    Cuneyt Turkmen
    Duygu Has
    Goknur Isik
    Oktar Asoglu
    Yersu Kapran
    Isik Adalet
    Annals of Nuclear Medicine, 2012, 26 : 551 - 558
  • [43] The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels
    Sanli, Yasemin
    Kuyumcu, Serkan
    Ozkan, Zeynep Gozde
    Kilic, Leyla
    Balik, Emre
    Turkmen, Cuneyt
    Has, Duygu
    Isik, Goknur
    Asoglu, Oktar
    Kapran, Yersu
    Adalet, Isik
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (07) : 551 - 558
  • [44] Role of [18F]FDG-PET/CT in Evaluation of Tumor Response to Chemoradiation Therapy for Advanced Colorectal Cancer
    Soni, Abhishek
    Chandola, Stuti
    Das, Chandan Jyoti
    Sharma, Raju
    Pathy, Sushmita
    Bhattacharjee, Hemanaga Kumar
    Chandrashekhara, Sheragaru Hanumanthappa
    Sharma, Atul
    Kumar, Rakesh
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 39 (04): : 279 - 285
  • [45] Preoperative chemotherapy for colorectal liver metastases: prediction of response by DCE-MRI and FDG-PET/CT?
    De Bruyne, S.
    Smeets, P.
    Van Damme, N.
    Ceelen, W.
    Van de Wiele, C.
    Laurent, S.
    Geboes, K.
    Mertens, J.
    Peeters, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S195 - S195
  • [46] FDG-PET/CT (PET) in the early prediction of benefit from first-line chemotherapy plus bevacizumab (bev) in metastatic colorectal cancer (mCRC).
    Salvatore, Lisa
    Loupakis, Fotios
    Cremolini, Chiara
    Schirripa, Marta
    Antoniotti, Carlotta
    Marmorino, Federica
    Zoratto, Federica
    Bergamo, Francesca
    Brunetti, Isa Maura
    Pfanner, Elisabetta
    Masi, Gianluca
    Genovesi, Dario
    Filidei, Elena
    Giorgetti, Assuero
    Falcone, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] The prognostic relevance of response evaluation to chemotherapy by FDG-PET/CT in patients with metastatic non-small-cell lung cancer
    Selcuk, Nalan
    Toklu, Turkay
    Ordu, Cetin
    Uluc, Basak
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [48] FDG-PET scan in colorectal cancer
    Dane, Faysal
    Dede, Fuat
    Atasoy, Beste M.
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2008, 18 (02): : 121 - 128
  • [49] The prognostic relevance of response evaluation to chemotherapy by FDG-PET/CT in patients with metastatic non-small cell lung cancer
    Ordu, C.
    Selcuk, N. Alan
    Akosman, C.
    Oyan, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST
    Vogsen, Marianne
    Bulow, Jakob Lykke
    Ljungstrom, Lasse
    Oltmann, Hjalte Rasmus
    Alamdari, Tural Asgharzadeh
    Naghavi-Behzad, Mohammad
    Braad, Poul-Erik
    Gerke, Oke
    Hildebrandt, Malene Grubbe
    DIAGNOSTICS, 2021, 11 (04)
12345